- Home
- CVEO vs VNDA Comparison
CVEO vs VNDA Comparison
Compare CVEO & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVEO
- VNDA
- Stock Information
- Founded
- CVEO 1977
- VNDA 2002
- Country
- CVEO United States
- VNDA United States
- Employees
- CVEO N/A
- VNDA 368
- Industry
- CVEO Hotels/Resorts
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- CVEO Consumer Discretionary
- VNDA Health Care
- Exchange
- CVEO Nasdaq
- VNDA Nasdaq
- Market Cap
- CVEO 281.2M
- VNDA 288.2M
- IPO Year
- CVEO N/A
- VNDA 2006
- Fundamental
- Price
- CVEO $24.11
- VNDA $4.78
- Analyst Decision
- CVEO Strong Buy
- VNDA Strong Buy
- Analyst Count
- CVEO 1
- VNDA 3
- Target Price
- CVEO $27.00
- VNDA $15.33
- AVG Volume (30 Days)
- CVEO 78.2K
- VNDA 408.4K
- Earning Date
- CVEO 07-29-2025
- VNDA 07-30-2025
- Dividend Yield
- CVEO 3.09%
- VNDA N/A
- EPS Growth
- CVEO N/A
- VNDA N/A
- EPS
- CVEO N/A
- VNDA N/A
- Revenue
- CVEO $660,046,000.00
- VNDA $201,351,000.00
- Revenue This Year
- CVEO N/A
- VNDA $16.86
- Revenue Next Year
- CVEO $4.45
- VNDA $39.78
- P/E Ratio
- CVEO N/A
- VNDA N/A
- Revenue Growth
- CVEO N/A
- VNDA 13.37
- 52 Week Low
- CVEO $18.01
- VNDA $3.81
- 52 Week High
- CVEO $28.92
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- CVEO 63.62
- VNDA 53.88
- Support Level
- CVEO $23.47
- VNDA $4.85
- Resistance Level
- CVEO $24.59
- VNDA $5.12
- Average True Range (ATR)
- CVEO 0.63
- VNDA 0.18
- MACD
- CVEO 0.09
- VNDA 0.01
- Stochastic Oscillator
- CVEO 84.19
- VNDA 54.05
About CVEO Civeo Corporation (Canada)
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.